Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 209,800 | 205,700 | 213,100 | 195,900 | 210,600 |
| Cost of Goods | 63,000 | 61,900 | 61,300 | 61,700 | 59,700 |
| Gross Profit | 146,800 | 143,800 | 151,800 | 134,200 | 150,900 |
| Operating Expenses | 152,500 | 168,000 | 481,300 | 163,900 | 190,700 |
| Operating Income | -5,700 | -23,300 | -329,200 | -29,000 | -39,100 |
| Interest Expense | 4,400 | 3,800 | 1,500 | 800 | 700 |
| Other Income | 1,200 | 900 | 100 | 400 | 600 |
| Pre-tax Income | -8,900 | -26,200 | -330,600 | -29,400 | -39,200 |
| Income Tax | -1,000 | 1,200 | -100 | -29,300 | 3,300 |
| Net Income Continuous | -7,900 | -27,400 | -330,500 | -100 | -42,500 |
| Net Income | $-7,900 | $-27,400 | $-330,500 | $-100 | $-42,500 |
| EPS Basic Total Ops | -0.09 | -0.29 | -3.57 | 0.00 | -0.47 |
| EPS Basic Continuous Ops | -0.08 | -0.29 | -3.57 | 0.00 | -0.47 |
| EPS Diluted Total Ops | -0.09 | -0.29 | -3.57 | 0.00 | -0.47 |
| EPS Diluted Continuous Ops | -0.08 | -0.29 | -3.57 | 0.00 | -0.47 |
| EPS Diluted Before Non-Recurring Items | 0.02 | -0.13 | -0.06 | -0.14 | -0.09 |
| EBITDA(a) | $9,600 | $-10,700 | $1,600 | $-14,600 | $18,700 |